PALISADE CAPITAL MANAGEMENT, LP - DERMIRA INC ownership

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of DERMIRA INC
ValueSharesWeighting
Q4 2019$5,011,000
+10.5%
5,392,0000.0%0.14%
+2.2%
Q3 2019$4,533,000
-3.0%
5,392,0000.0%0.14%
-3.5%
Q2 2019$4,674,000
-17.6%
5,392,000
-15.6%
0.14%
-20.9%
Q1 2019$5,669,000
+15.1%
6,392,0000.0%0.18%
+0.6%
Q4 2018$4,926,000
-17.1%
6,392,000
-10.5%
0.18%
+10.4%
Q3 2018$5,944,000
+0.9%
7,142,0000.0%0.16%
-3.5%
Q2 2018$5,892,0007,142,0000.17%
Other shareholders
DERMIRA INC shareholders Q3 2023
NameSharesValueWeighting ↓
PFM Health Sciences, LP 30,558,000$26,441,0000.50%
DeepCurrents Investment Group LLC 11,083,000$5,809,0000.50%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 23,200,000$20,007,000,0000.39%
Castle Creek Arbitrage, LLC 1,006,000$872,0000.23%
Polar Capital LLP 24,750,000$21,416,0000.19%
Partner Investment Management, L.P. 192,000$166,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 5,392,000$4,674,0000.14%
CSS LLC/IL 2,450,000$2,129,0000.12%
Verition Fund Management LLC 4,832,000$4,181,0000.12%
OAKTREE CAPITAL MANAGEMENT LP 6,380,000$5,521,0000.10%
View complete list of DERMIRA INC shareholders